Orthopedics This Week

SYK Juggles Sales and Profits for Q1 2025

Stryker Corporation’s opening quarter of 2025 was, to paraphrase one Wall Street analysts, a “top, middle and bottom beat” meaning better than expected sales, op profits and EBITDA.

More audio from Orthopedics This Week